On August 20 2019, Cuu Long Pharmaceutical Joint Stock Company (DCL) held a meeting with its distributors in the northern region to express gratitude for the cooperation throughout the past period.
The meeting and gratitude ceremony to customers in the north with participation of board of directors and senior managers of Cuu Long Pharmaceutical showed the great interest of the company to customers.
In the meeting, nearly 30 distributors in the north of Cuu Long Pharmaceutical not only introduced more information about DCL and FIT Group which is DCL’s mother company but also learned more about products, strategies, sale policy and orientation of DCL in the future. In addition, Board of Management and Board of Directors pay close attention to listening to customers’ opinions to help the company make improvements in its products, distribution channels, and customer care systems so that can meet needs as well as strengthen long-term cooperation with company’s distributors.
Mr. Nguyen Van Sang – BOD cum CEO, listen and answer question from distributor
Speaking at the meeting and gratitude, Mr. Nguyen Van Sang – Chairman and CEO of DCL emphasized the important role of distributors in the development of DCL. Through that, Mr. Sang shared gratitude to all distributors who have accompanied and supported DCL during the past time. And to express our great gratitude to our customers, DCL has honored the most outstanding and active distributors as well as the biggest growth steps from 2016 to 2018; especially the most active distributor in the first half of 2019.
Following the customer gratitude series, DCL will hold a meeting of the company’s distributors in the southern region in the middle of the last week of August. Meeting and customer appreciation is an annual activity of DCL and an opportunity for Board of Directors of the company to meet with distributors to share and continue to strengthen cooperation of DCL and customers.
Honor to Outstanding Distributors
In 2015, DCL had encountered great difficulties and challenges due to changes in market trends. Since becoming a member of FIT Group, DCL has been oriented and invested by the parent company to access to modern infrastructure and equipment as well as restructure. Currently, DCL has been making strides with big and potential projects, contributing to ensure the strong development of the company in the future, to become one of the leading pharmaceutical companies in Vietnam, recognized and appreciated by patients, staff and partners for the best innovative, accessible and caring products and services.
